Kevin M. Levine

1.4k total citations
22 papers, 718 citations indexed

About

Kevin M. Levine is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kevin M. Levine has authored 22 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Kevin M. Levine's work include Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (3 papers) and Breast Cancer Treatment Studies (3 papers). Kevin M. Levine is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Epigenetics and DNA Methylation (3 papers) and Breast Cancer Treatment Studies (3 papers). Kevin M. Levine collaborates with scholars based in United States, China and Saudi Arabia. Kevin M. Levine's co-authors include Steffi Oesterreich, Nilgun Tasdemir, Adrian V. Lee, Matthew J. Sikora, Nancy E. Davidson, Tian Du, Kai Ding, Britta M. Jacobsen, Zheqi Li and Bennett Van Houten and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Kevin M. Levine

21 papers receiving 711 citations

Peers

Countries citing papers authored by Kevin M. Levine

Since Specialization

Citations

This map shows the geographic impact of Kevin M. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin M. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin M. Levine more than expected).

Fields of papers citing papers by Kevin M. Levine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin M. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin M. Levine. The network helps show where Kevin M. Levine may publish in the future.

Co-authorship network of co-authors of Kevin M. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin M. Levine. A scholar is included among the top collaborators of Kevin M. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin M. Levine. Kevin M. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osimertinib retreatment for patients with advanced EGFR-mutated non-small cell lung cancer 2025 ·Cancer Treatment and Research Communications ·Kevin M. Levine, (unknown), Ted Gooley, Jenna Voutsinas, (unknown), Keith D. Eaton, Rafael Santana-Dávila, Alice H. Berger, Christina S. Baik	0
2	The genomic landscape of lung cancer in never-smokers from the Women’s Health Initiative 2024 ·JCI Insight ·Sitapriya Moorthi, Amy L. Paguirigan, (unknown), Minjeong Ko, Mary Pettinger, (unknown), Anwesha Nag, (unknown), Feinan Wu, (unknown), Kevin M. Levine, Matthew Fitzgibbon, Aaron R. Thorner, Garnet L. Anderson, Gavin Ha, Alice H. Berger	4
3	Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma 2020 ·Endocrinology ·Sreeja Sreekumar, Kevin M. Levine, Matthew J. Sikora, Jian Chen, Nilgun Tasdemir, (unknown), David J. Dabbs, (unknown), Ahmed Basudan, David N. Boone, Priscilla F. McAuliffe, Rachel C. Jankowitz, Adrian V. Lee, Jennifer M. Atkinson, Steffi Oesterreich	12
4	Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells 2020 ·Cancer Research ·Fangyuan Chen, Kai Ding, Nolan Priedigkeit, (unknown), Kevin M. Levine, Neil Carleton, (unknown), Jennifer M. Atkinson, Steffi Oesterreich, Adrian V. Lee	28
5	Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma 2020 ·Scientific Reports ·Nilgun Tasdemir, Kai Ding, (unknown), Kevin M. Levine, Tian Du, (unknown), (unknown), Adrian V. Lee, Nancy E. Davidson, (unknown)	14
6	FGFR4: A promising therapeutic target for breast cancer and other solid tumors 2020 ·Pharmacology & Therapeutics ·Kevin M. Levine, Kai Ding, (unknown), Steffi Oesterreich	56
7	FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype 2019 ·npj Breast Cancer ·Kevin M. Levine, Nolan Priedigkeit, Ahmed Basudan, Nilgun Tasdemir, Matthew J. Sikora, Ethan S. Sokol, Ryan J. Hartmaier, Kai Ding, (unknown), Rebecca Watters, Kurt R. Weiss, Jens‐Uwe Blohmer, Carsten Denkert, (unknown), Maria Margarete Karsten, M.M. Boisen, Esther Elishaev, Peter C. Lucas, Adrian V. Lee, Steffi Oesterreich	41
8	SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma 2019 ·Breast Cancer Research and Treatment ·(unknown), Nilgun Tasdemir, Matthew J. Sikora, Amir Bahreini, Kevin M. Levine, Jian Chen, Ahmed Basudan, Britta M. Jacobsen, Timothy F. Burns, (unknown)	10
9	Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma 2019 ·Cancer Letters ·Lan Cao, Ahmed Basudan, Matthew J. Sikora, Amir Bahreini, Nilgun Tasdemir, Kevin M. Levine, Rachel C. Jankowitz, Priscilla F. McAuliffe, David J. Dabbs, Sue Haupt, Ygal Haupt, Peter C. Lucas, Adrian V. Lee, Steffi Oesterreich, Jennifer M. Atkinson	14
10	Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures 2018 ·Cancer Research ·Nilgun Tasdemir, (unknown), Zheqi Li, Li Zhu, Matthew J. Sikora, Kevin M. Levine, Britta M. Jacobsen, George C. Tseng, Nancy E. Davidson, Steffi Oesterreich	44
11	Loss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors 2018 ·Clinical Cancer Research ·(unknown), Kevin M. Levine, Nilgun Tasdemir, Julie A. Scott, (unknown), (unknown), Tiffany A. Katz, David N. Boone, Britta M. Jacobsen, Jennifer M. Atkinson, (unknown), Adrian V. Lee	54
12	Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer 2018 ·Breast Cancer Research ·Tian Du, Matthew J. Sikora, Kevin M. Levine, Nilgun Tasdemir, Rebecca B. Riggins, Stacy G. Wendell, Bennett Van Houten, Steffi Oesterreich	72
13	Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism 2018 ·Scientific Reports ·Tian Du, Li Zhu, Kevin M. Levine, Nilgun Tasdemir, Adrian V. Lee, Dario A.A. Vignali, Bennett Van Houten, George C. Tseng, Steffi Oesterreich	58
14	Targeting adenosine receptor 2B in triple negative breast cancer 2018 ·Journal of Cancer Metastasis and Treatment ·Carola A. Neumann, Kevin M. Levine, (unknown)	6
15	A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7 2017 ·Antioxidants and Redox Signaling ·Barbara Hopkins, Monica J. S. Nadler, John Skoko, Thierry Bertomeu, Andrea Pelosi, (unknown), Kevin M. Levine, (unknown), Bodvaël Pennarun, Bo Yang, Dipak Datta, Octavian Bucur, Kenneth Ndebele, (unknown), Da Yang, Maria Giulia Rizzo, Roya Khosravi‐Far, Carola A. Neumann	49
16	Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models 2017 ·Breast Cancer Research ·Amir Bahreini, Zheqi Li, Peilu Wang, Kevin M. Levine, Nilgun Tasdemir, Lan Cao, Hazel M. Weir, Shannon L. Puhalla, Nancy E. Davidson, Andrew M. Stern, David Chu, Ben Ho Park, Adrian V. Lee, Steffi Oesterreich	101
17	Non-coding single nucleotide variants affecting estrogen receptor binding and activity 2016 ·Genome Medicine ·Amir Bahreini, Kevin M. Levine, Lucas Santana‐Santos, Panayiotis V. Benos, Peilu Wang, Courtney L. Andersen, Steffi Oesterreich, Adrian V. Lee	6
18	WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines 2016 ·Breast Cancer Research ·Matthew J. Sikora, Britta M. Jacobsen, Kevin M. Levine, Jian Chen, Nancy E. Davidson, Adrian V. Lee, Caroline M. Alexander, Steffi Oesterreich	47
19	The Histone Database: an integrated resource for histones and histone fold-containing proteins 2011 ·Database ·(unknown), Kevin M. Levine, Manuel R. González Morales, Shu Zhang, R. Travis Moreland, A. D. Baxevanis, David Landsman	37
20	SODIUM RESTRICTION IN HYPERTENSION 2009 ·Nutrition Reviews ·H. G. Langford, David G. Schlundt, Kevin M. Levine	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact